It's nice to see the Clearside Biomedical, Inc. ( NASDAQ:CLSD ) share price up 13% in a week. But that doesn't ...

George Lasezkay, PharmD, JD, President and Chief Executive Officer, Clearside Biomedical, commented, “Tony is a highly respected member of our Board, bringing a wealth of strategic leadership ...

A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months.

Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - ...

ALPHARETTA, Ga. - Clearside Biomedical, Inc. (NASDAQ:CLSD), a company focused on developing treatments for eye diseases, announced the appointment of Tony Gibney as Chair of its Board of Directors ...

CHASKA, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing ...

Binghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.

Arcellx, Inc. (ACLX) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.81 per share a year ago. These figures are ...